DPY19L3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.11849990275448E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.2469999718171E-09 |
Normal-vs-Stage2 |
2.13639999999682E-05 |
Normal-vs-Stage3 |
1.26379999798587E-08 |
Normal-vs-Stage4 |
6.86259999937988E-08 |
Stage1-vs-Stage2 |
5.688000E-01 |
Stage1-vs-Stage3 |
7.600100E-02 |
Stage1-vs-Stage4 |
1.351760E-01 |
Stage2-vs-Stage3 |
4.770600E-01 |
Stage2-vs-Stage4 |
5.925600E-01 |
Stage3-vs-Stage4 |
8.521000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.32879998513158E-09 |
Normal-vs-AfricanAmerican |
2.38810082819896E-11 |
Normal-vs-Asian |
2.738400E-02 |
Caucasian-vs-AfricanAmerican |
5.083100E-03 |
Caucasian-vs-Asian |
9.728400E-01 |
AfricanAmerican-vs-Asian |
2.358000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.38360001233906E-09 |
Normal-vs-Female |
7.98519994571478E-09 |
Male-vs-Female |
4.166400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.84769999999457E-05 |
Normal-vs-Age(41-60Yrs) |
7.89540000045719E-08 |
Normal-vs-Age(61-80Yrs) |
1.69829994511872E-09 |
Normal-vs-Age(81-100Yrs) |
5.27430000007989E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.462600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.058800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.008200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.549000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.701700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.615840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.243780E-01 |
Normal-vs-Grade 2 |
1.64406999999533E-05 |
Normal-vs-Grade 3 |
1.03700381615113E-11 |
Normal-vs-Grade 4 |
5.29359889256398E-11 |
Grade 1-vs-Grade 2 |
4.268800E-01 |
Grade 1-vs-Grade 3 |
5.705800E-02 |
Grade 1-vs-Grade 4 |
1.400320E-02 |
Grade 2-vs-Grade 3 |
1.536220E-02 |
Grade 2-vs-Grade 4 |
2.279500E-03 |
Grade 3-vs-Grade 4 |
2.155600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.87949999961046E-07 |
Normal-vs-ccB subtype |
8.42899999797808E-08 |
ccA subtype-vs-ccB subtype |
9.276300E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.65830000018208E-07 |
Normal-vs-N1 |
1.786370E-04 |
N0-vs-N1 |
2.687800E-01 |
|
|